Zantac 75 Efferdose
Company: GlaxoWellcome
Approval Status: Approved March 1998
Treatment for: heartburn
Areas: Gastroenterology
General Information
Other Useful Resources
Zantac 75 Efferdose has been approved for the treatment of heartburn. It is the first over-the-counter effervescent H2 antagonist.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
